Learn More...

Select a Disease Condition

 l Five More Formulations Registered in
         Hong Kong

 l Thyrox Registered in Hong Kong

 l UNICEF and SMC Place Orders for
        Sprinkles

 l 2007 Half Yearly Results --- Earnings Rise
         by 44%

 l MHRA Approves Renata Potent Product 
         Facility       IMAGES

 l AGM approves 50% cash & 20% stock 
        dividend  

 l Chairman's Speech

 l 2006 Results 

 l 2006 AGM Pictures 

 l UNICEF Approves Renata Sachet Filling  
         Facility  

 l Renata Declares 50% Cash Dividend and  
         20% (5:1) Stock Dividend

 l Renata will provide Technical Assistance  
      to Al-Arabia Pharmaceutical Industries, Syria

 l Renata will manufacture Sprinkles  
      for SMC

 l Four New Manufacturing Facilities 
      Commissioned in 2006

 l 1st Half 2006 Results   

 l Chairman's Report, 33rd Annual General  
       Meeting

 l 2005 Results

 l More Contract Manufacturing Business  
       from Eskayef   

 l Renata Earning per Share Rockets to  
       Second Place at DSE

  l Agreement with Ped Med Ltd (Canada)

    l Renata Participate at CPhI,Madrid

 l 1st Half 2005 Results   

  l Valdex Withdrawn Following Pfizer's  
          Decision to Withdraw Bextra

  l Dhaka Stock Exchange Ranks Renata  
          Among Top 10 Performers 

l Therapeutics to Manufacture Oral Liquid,  
      Animal Health, and Penicillin Products     
      on Behalf of Renata

l 1st Half 2005 Results

l Dhaka Stock Exchange Ranks Renata Among Top 10 Performers  

l Renata Limited Enters Vietnam Pharmaceuticals Market

     l Therapeutics to Manufacture Oral Liquid, Animal Health and Penicillin Products on behalf of Renata

l Eskayef Renews Contract for Cephalosporin Formulations

l Goldshield Group PLC and Renata Sign Confidentiality Agreement

l Renata Begins Nationwide Rabies Awareness Campaign

l 32nd Annual General Meeting Held

l 1st Half 2004 Results

l 2004 Results

lAnnual Report 2004

l ORS Plant - Sleepless at Renata

l SMC Renews Co-Packer Agreement With Renata  

l 31st Annual General Meeting Held

l Chairman's Report to the Shareholders of the 31st Annual General Meeting

l Renata declares 50% cash dividend plus 20% bonus share (stock dividend)

l Renata Withdraws Fexib Following Merck's Decision to Withdraw Vioxx

l  Distribution Agreement with Evans Vanodine International

l Renata increases its Shareholding in BRAC-Renata Agro Industries Limited from

    49% to 100%.

l New agreement signed with SMC

l Renata to continue manufacture ORSaline for SMC

l Renata to market Chiron

l Renata to manufacture ORSaline for SMC

l Hoechst AG assigns ownership of Trademarks to Renata

l Renata will manufacture BRAC Saline for BRAC

l Renata Limited has been awarded ISO 9001 certification by DNV